Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca - Barron's

Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca - Barron's
Business

Listen to this article

0%

A potential tie-up betweenBristol Myers SquibbandAstraZenecais looking less and less like a good deal to Wall Street. Copyright ©2026Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818… [+17 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected